The Japan Diagnostic Contract Manufacturing Market was valued at $2393.3 Million in 2023 and projected to reach to $4297.9 Million by 2028, representing a compound annual growth rate of 12.4%. Japan's diagnostic contract manufacturing market is poised for significant expansion through 2028, driven by escalating demand for innovative IVD solutions and Japan's reputation for manufacturing excellence.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan's diagnostic contract manufacturing market valued at $2,393.3 million in 2023, projected to reach $4,297.9 million by 2028, with a robust CAGR of 12.4%.
Increasing demand for in vitro diagnostic devices in Japan is driving market expansion, supported by aging population demographics and prevalence of chronic diseases requiring diagnostic testing.
Rising healthcare expenditure in Japan combined with government initiatives to modernize diagnostic infrastructure is accelerating contract manufacturing outsourcing among domestic and international players.
Japan's advanced manufacturing capabilities, precision engineering expertise, and stringent quality standards position the country as a preferred hub for diagnostic device contract manufacturing in Asia-Pacific.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | CARDIOLOGY (Application) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 11.5% from 2023 to 2028 |
| Largest Segment | DEVICE DEVELOPMENT AND MANUFACTURING SERVICES (Service) |
| Market Size Base Year (Billions) | ~USD 26.05 (2023) |
| Revenue Forecast (Billions) | ~USD 44.9 (2028) |
| Segments Covered | Device Type, Type, Service, Application |
4 segment dimensions are covered across the global market.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CARDIOLOGY | 109.4 | 122.1 | 139.1 | 158.4 | 180.6 | 206.2 | 235.1 | 268 | 14 |
| DIABETES | 174 | 188.4 | 208 | 229.7 | 253.9 | 281.1 | 310.7 | 343.4 | 10.5 |
| INFECTIOUS DISEASES | 446.6 | 493.7 | 556.4 | 626.8 | 706.4 | 797.3 | 897.7 | 1010.4 | 12.7 |
| ONCOLOGY | 147.5 | 163.7 | 185.4 | 209.9 | 237.8 | 270 | 306 | 346.7 | 13.3 |
| OTHER APPLICATIONS | 306.9 | 331.3 | 364.7 | 401.6 | 442.5 | 488.4 | 538.2 | 592.9 | 10.2 |
| TOTAL | 1184.4 | 1299.2 | 1453.6 | 1626.4 | 1821.2 | 2043 | 2287.7 | 2561.4 | 12 |
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| GASTROENTEROLOGY | 47.4 | 53.4 | 61.2 | 70 | 80.1 | 91.7 | 104.8 | 119.7 | 14.4 |
| GYNECOLOGY | 42.5 | 47.8 | 54.9 | 63.1 | 72.6 | 83.7 | 96.2 | 110.6 | 15 |
| OTHER APPLICATIONS | 102.2 | 111.4 | 123.8 | 137.7 | 153.2 | 170.8 | 190 | 211.4 | 11.3 |
| TOTAL | 192.1 | 212.6 | 239.9 | 270.8 | 305.9 | 346.2 | 391 | 441.7 | 13 |
Japan's diagnostic contract manufacturing market was valued at $2,393.3 million in 2023 and is expected to grow to $4,297.9 million by 2028.
Japan's diagnostic contract manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 12.4% from 2023 to 2028.
Key growth drivers in Japan include an aging population, rising healthcare expenditure, increased demand for IVD devices, advanced manufacturing capabilities, and emphasis on preventive healthcare.
Japan is preferred due to its strong pharmaceutical and medical device infrastructure, stringent quality standards, regulatory compliance frameworks, advanced automation capabilities, and reputation for precision engineering.
By 2028, Japan's sector is expected to expand through increased investment in automation, digital integration, technological innovation, and strategic global partnerships, solidifying its position as a regional manufacturing hub.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product/service launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the diagnostic contract manufacturing market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the diagnostic contract manufacturing market. A database of the key industry leaders was also prepared using secondary research.
The primary research data was conducted after acquiring knowledge about the diagnostic contract manufacturing market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as clinical laboratories, hospitals, and academic & research institutes) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, and Rest of the World. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:

Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
All major product manufacturers offering various sleep apnea were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value diagnostic contract manufacturing market was also split into various segments and subsegments at the regional and country level based on the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Diagnostic contract manufacturing industry.
Diagnostic contract manufacturing is a process wherein a manufacturing company makes diagnostic devices or the components of devices that can be sold later by other companies. Diagnostic device contract manufacturers specialize in a certain process or task and offer expertise due to their frequent practice of manufacturing.
MarketsandMarkets offers the following customizations for this market report:
Additional country-level analysis of the Diagnostic contract manufacturing market
Full forecast, segment splits, and company analysis for all Diagnostic Contract Manufacturing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report